Sonnet BioTherapeutics Holdings, Inc. 8-K Filing
| Field | Detail |
|---|---|
| Company | Sonnet Biotherapeutics Holdings, Inc. |
| Form Type | 8-K |
| Filed Date | Sep 29, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: SONN
TL;DR
Sonnet BioTherapeutics (SONN) filed an 8-K for a shareholder vote on 9/26. Watch for updates.
AI Summary
Sonnet BioTherapeutics Holdings, Inc. filed an 8-K on September 29, 2025, reporting on matters submitted to a vote of security holders as of September 26, 2025. The company, previously known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC, is incorporated in Delaware and headquartered in Princeton, NJ.
Why It Matters
This filing indicates that Sonnet BioTherapeutics Holdings, Inc. held a vote of its security holders, which could signal significant corporate actions or changes in governance.
Risk Assessment
Risk Level: medium — An 8-K filing related to a vote of security holders can indicate significant corporate events, which may carry inherent risks.
Key Players & Entities
- Sonnet BioTherapeutics Holdings, Inc. (company) — Registrant
- Chanticleer Holdings, Inc. (company) — Former company name
- TULVINE SYSTEMS INC (company) — Former company name
- September 26, 2025 (date) — Date of earliest event reported
- September 29, 2025 (date) — Filing date
- 001-35570 (other) — Commission File Number
FAQ
What specific matters were submitted to a vote of Sonnet BioTherapeutics Holdings, Inc. security holders?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals voted upon in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on September 26, 2025.
What is the filing date of this 8-K report?
This 8-K report was filed on September 29, 2025.
What is the principal executive office address for Sonnet BioTherapeutics Holdings, Inc.?
The principal executive office is located at 100 Overlook Center, Suite 102, Princeton, NJ 08540.
Has Sonnet BioTherapeutics Holdings, Inc. operated under any previous names?
Yes, the company was formerly known as Chanticleer Holdings, Inc. and TULVINE SYSTEMS INC.
Filing Stats: 755 words · 3 min read · ~3 pages · Grade level 15.3 · Accepted 2025-09-29 16:05:39
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share SONN The Nasdaq Capital M
Filing Documents
- form8-k.htm (8-K) — 50KB
- 0001493152-25-015994.txt ( ) — 212KB
- sonn-20250926.xsd (EX-101.SCH) — 3KB
- sonn-20250926_lab.xml (EX-101.LAB) — 33KB
- sonn-20250926_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Sonnet BioTherapeutics Holdings, Inc. September 29, 2025 By: /s/ Raghu Rao Name: Raghu Rao Title: Interim Chief Executive Officer